Literature DB >> 14720218

Cathepsin B mRNA and protein expression following contusion spinal cord injury in rats.

Rebecca C Ellis1, J Nicole Earnhardt, Ronald L Hayes, Kevin K W Wang, Douglas K Anderson.   

Abstract

We provide the first data that cathepsin B (Cath B), a lysosomal cysteine protease, is up-regulated following contusion-spinal cord injury (SCI). Following T12 laminectomy and moderate contusion, Cath B mRNA and protein expression profiles were examined from 2 to 168 h post-injury in rats using real-time PCR and immunoblots, respectively. Contusion injury significantly increased [mRNA]Cath B in the injury site and adjacent segments over sham injury levels. While the largest [mRNA]Cath B induction (20-fold over naive) was seen in the injury site, the caudal segment routinely yielded [mRNA]Cath B levels greater than 10-fold over naive. Interestingly, sham injury animals also experienced mRNA induction at several time points at the injury site and in segments rostral and caudal to the injury site. Contusion injury also significantly elevated levels of Cath B proenzyme protein (37 kDa) over sham injury in the injury site (48, 72 and 168 h post-injury). Furthermore, significant protein increases of single and double chain Cath B (both active forms) occurred at the injury site at 72 and 168 h post-injury. Similar significant increases in Cath B protein levels were seen in areas adjacent to the injury site. The induction of Cath B mRNA and protein expression following contusion injury is previously undescribed and suggests that Cath B may potentially be involved in the secondary injury cascade, perhaps for as long as 1 week post-injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720218     DOI: 10.1046/j.1471-4159.2003.02197.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Improvement in recovery after experimental intracerebral hemorrhage using a selective cathepsin B and L inhibitor.

Authors:  Dongmei Yang; Yuxia Han; Jianfeng Zhang; Christopher Ding; John Anagli; Donald M Seyfried
Journal:  J Neurosurg       Date:  2010-07-30       Impact factor: 5.115

Review 2.  Inhibition of cysteine proteases in acute and chronic spinal cord injury.

Authors:  Swapan K Ray; Supriti Samantaray; Joshua A Smith; Denise D Matzelle; Arabinda Das; Naren L Banik
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice.

Authors:  Gulyeter Serbest; Matthew F Burkhardt; Robert Siman; Ramesh Raghupathi; Kathryn E Saatman
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 4.  Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.

Authors:  Gregory Hook; Thomas Reinheckel; Junjun Ni; Zhou Wu; Mark Kindy; Christoph Peters; Vivian Hook
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 5.  The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries.

Authors:  George Anis Sarkis; Manasi D Mangaonkar; Ahmed Moghieb; Brian Lelling; Michael Guertin; Hamad Yadikar; Zhihui Yang; Firas Kobeissy; Kevin K W Wang
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

6.  Enhanced functional recovery in MRL/MpJ mice after spinal cord dorsal hemisection.

Authors:  Sandrine Thuret; Michaela Thallmair; Laura L Horky; Fred H Gage
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

Review 7.  Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.

Authors:  Vivian Hook; Michael Yoon; Charles Mosier; Gen Ito; Sonia Podvin; Brian P Head; Robert Rissman; Anthony J O'Donoghue; Gregory Hook
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-04-17       Impact factor: 3.036

Review 8.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.